Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications

被引:10
|
作者
Friberger, Ida [1 ]
Jussing, Emma [2 ,3 ]
Han, Jinming [1 ,4 ]
Goos, Jeroen A. C. M. [1 ,2 ,3 ]
Siikanen, Jonathan [2 ,5 ]
Kaipe, Helen [6 ,7 ]
Lambert, Melanie [8 ]
Harris, Robert A. [1 ,4 ]
Samen, Erik [2 ,3 ]
Carlsten, Mattias [8 ,9 ]
Holmin, Staffan [1 ,10 ]
Tran, Thuy A. [1 ,2 ,3 ]
机构
[1] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[2] Karolinska Inst, Dept Oncol & Pathol, Stockholm, Sweden
[3] Karolinska Univ Hosp, Dept Radiopharm, Stockholm, Sweden
[4] Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden
[5] Karolinska Univ Hosp, Dept Med Radiat Phys & Nucl Med, Stockholm, Sweden
[6] Karolinska Inst, Dept Lab Med, Stockholm, Sweden
[7] Karolinska Univ Hosp, Dept Clin Immunol & Transfus Med, Stockholm, Sweden
[8] Karolinska Inst, Dept Med Huddinge, Stockholm, Sweden
[9] Karolinska Univ Hosp, Ctr Cell Therapy & Allogene Stem Cell Transplanta, Stockholm, Sweden
[10] Karolinska Univ Hosp, Dept Neuroradiol, Stockholm, Sweden
基金
瑞典研究理事会;
关键词
Cell labelling; Cell tracking; Zr-89; Oxine; Deferoxamine; PET; Imaging; DONOR LYMPHOCYTE INFUSION; DECIDUAL STROMAL CELLS; TRACKING; LEUKOCYTES; PET; CYTOTOXICITY; LEUKEMIA; RELAPSE;
D O I
10.1007/s11307-021-01622-z
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background There is a need to better characterise cell-based therapies in preclinical models to help facilitate their translation to humans. Long-term high-resolution tracking of the cells in vivo is often impossible due to unreliable methods. Radiolabelling of cells has the advantage of being able to reveal cellular kinetics in vivo over time. This study aimed to optimise the synthesis of the radiotracers [Zr-89]Zr-oxine (8-hydroxyquinoline) and [Zr-89]Zr-DFO-NCS (p-SCN-Bn-Deferoxamine) and to perform a direct comparison of the cell labelling efficiency using these radiotracers. Procedures Several parameters, such as buffers, pH, labelling time and temperature, were investigated to optimise the synthesis of [Zr-89]Zr-oxine and [Zr-89]Zr-DFO-NCS in order to reach a radiochemical conversion (RCC) of >95 % without purification. Radio-instant thin-layer chromatography (iTLC) and radio high-performance liquid chromatography (radio-HPLC) were used to determine the RCC. Cells were labelled with [Zr-89]Zr-oxine or [Zr-89]Zr-DFO-NCS. The cellular retention of Zr-89 and the labelling impact was determined by analysing the cellular functions, such as viability, proliferation, phagocytotic ability and phenotypic immunostaining. Results The optimised synthesis of [Zr-89]Zr-oxine and [Zr-89]Zr-DFO-NCS resulted in straightforward protocols not requiring additional purification. [Zr-89]Zr-oxine and [Zr-89]Zr-DFO-NCS were synthesised with an average RCC of 98.4 % (n = 16) and 98.0 % (n = 13), respectively. Cell labelling efficiencies were 63.9 % (n = 35) and 70.2 % (n = 30), respectively. Zr-89 labelling neither significantly affected the cell viability (cell viability loss was in the range of 1-8 % compared to its corresponding non-labelled cells, P value > 0.05) nor the cells' proliferation rate. The phenotype of human decidual stromal cells (hDSC) and phagocytic function of rat bone-marrow-derived macrophages (rMac) was somewhat affected by radiolabelling. Conclusions Our study demonstrates that [Zr-89]Zr-oxine and [Zr-89]Zr-DFO-NCS are equally effective in cell labelling. However, [Zr-89]Zr-oxine was superior to [Zr-89]Zr-DFO-NCS with regard to long-term stability, cellular retention, minimal variation between cell types and cell labelling efficiency.
引用
收藏
页码:952 / 962
页数:11
相关论文
共 17 条
  • [1] Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications
    Ida Friberger
    Emma Jussing
    Jinming Han
    Jeroen A. C. M. Goos
    Jonathan Siikanen
    Helen Kaipe
    Mélanie Lambert
    Robert A. Harris
    Erik Samén
    Mattias Carlsten
    Staffan Holmin
    Thuy A. Tran
    Molecular Imaging and Biology, 2021, 23 : 952 - 962
  • [2] Comparative in vivo biodistribution of cells labelled with [89Zr]Zr-(oxinate)4 or [89Zr]Zr-DFO-NCS using PET
    Friberger, Ida
    Nilsson, Joachim N. N.
    Lu, Li
    Siikanen, Jonathan
    Ardenfors, Oscar
    Milton, Stefan
    Samen, Erik
    Goos, Jeroen A. C. M.
    Carlsten, Mattias
    Holmin, Staffan
    Tran, Thuy A. A.
    EJNMMI RESEARCH, 2023, 13 (01)
  • [3] Comparative in vivo biodistribution of cells labelled with [89Zr]Zr-(oxinate)4 or [89Zr]Zr-DFO-NCS using PET
    Ida Friberger
    Joachim N. Nilsson
    Li Lu
    Jonathan Siikanen
    Oscar Ardenfors
    Stefan Milton
    Erik Samén
    Jeroen A. C. M. Goos
    Mattias Carlsten
    Staffan Holmin
    Thuy A. Tran
    EJNMMI Research, 13
  • [4] Biodistribution of Mesenchymal Stromal Cells Labeled with [89Zr]Zr-Oxine in Local Radiation Injuries in Laboratory Animals
    Astrelina, Tatiana A.
    Brunchukov, Vitaliy A.
    Kodina, Galina E.
    Bubenshchikov, Viktor B.
    Larenkov, Anton A.
    Lunev, Aleksandr S.
    Petrosova, Kristina A.
    Rastorgueva, Anna A.
    Kobzeva, Irina V.
    Usupzhanova, Daria Y.
    Nikitina, Victoria A.
    Malsagova, Kristina A.
    Kulikova, Ludmila I.
    Samoilov, Alexander S.
    Pustovoyt, Vasiliy I.
    MOLECULES, 2023, 28 (20):
  • [5] Toward Optimized 89Zr-Immuno-PET: Side-by-Side Comparison of [89Zr]Zr-DFO-, [89Zr]Zr-3,4,3-(LI-1,2-HOPO)- and [89Zr]Zr-DFO*-Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable?
    Damerow, Helen
    Cheng, Xia
    von Kiedrowski, Valeska
    Schirrmacher, Ralf
    Waengler, Bjoern
    Fricker, Gert
    Waengler, Carmen
    PHARMACEUTICS, 2022, 14 (10)
  • [6] A kit formulation for the preparation of [89Zr]Zr(oxinate)4 for PET cell tracking: White blood cell labelling and comparison with [111In]In(oxinate)3
    Man, Francis
    Khan, Azalea A.
    Carrascal-Minino, Amaia
    Blower, Philip J.
    de Rosales, Rafael T. M.
    NUCLEAR MEDICINE AND BIOLOGY, 2020, 90-91 : 31 - 40
  • [7] Novel 89Zr cell labeling approach for PET-based cell trafficking studies
    Bansal, Aditya
    Pandey, Mukesh K.
    Demirhan, Yunus E.
    Nesbitt, Jonathan J.
    Crespo-Diaz, Ruben J.
    Terzic, Andre
    Behfar, Atta
    DeGrado, Timothy R.
    EJNMMI RESEARCH, 2015, 5
  • [8] [89Zr]Oxinate4 for long-term in vivo cell tracking by positron emission tomography
    Charoenphun, Putthiporn
    Meszaros, Levente K.
    Chuamsaamarkkee, Krisanat
    Sharif-Paghaleh, Ehsan
    Ballinger, James R.
    Ferris, Trevor J.
    Went, Michael J.
    Mullen, Gregory E. D.
    Blower, Philip J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (02) : 278 - 287
  • [9] 89Zr-leukocyte labelling for cell trafficking: in vitro and preclinical investigations
    Kahts, Maryke
    Guo, Hua
    Kommidi, Harikrishna
    Yang, Yanping
    Sayman, Haluk Burcak
    Summers, Beverley
    Ting, Richard
    Zeevaart, Jan Rijn
    Sathekge, Mike
    Aras, Omer
    EJNMMI RADIOPHARMACY AND CHEMISTRY, 2023, 8 (01)
  • [10] Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* for 89Zr-immunoPET
    Raave, Rene
    Sandker, Gerwin
    Adumeau, Pierre
    Jacobsen, Christian Borch
    Mangin, Floriane
    Meyer, Michel
    Moreau, Mathieu
    Bernhard, Claire
    Da Costa, Laurene
    Dubois, Adrien
    Goncalves, Victor
    Gustafsson, Magnus
    Rijpkema, Mark
    Boerman, Otto
    Chambron, Jean-Claude
    Heskamp, Sandra
    Denat, Franck
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (09) : 1966 - 1977